DEVELOPMENT OF A THERAPEUTIC VACCINE FOR DYSLIPIDEMIA AND RELATED DISEASES TARGETING ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3).

被引:0
|
作者
Fukami, Hirotaka [1 ,2 ]
Morinaga, Jun [1 ,2 ]
Nakagami, Hironori [3 ]
Kuwabara, Takashige [1 ]
Morishita, Ryuichi [4 ]
Oike, Yuichi [2 ]
Mukoyama, Masashi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto, Japan
[3] Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, Suita, Osaka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
PS-BPB03-5
引用
收藏
页码:E270 / E271
页数:2
相关论文
共 50 条
  • [1] Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
    Chen, Pei-Yi
    Gao, Wan-Yun
    Liou, Je-Wen
    Lin, Ching-Yen
    Wu, Ming-Jiuan
    Yen, Jui-Hung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [2] Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia
    Shoji, Tetsuo
    Hatsuda, Sawako
    Tsuchikura, Shoko
    Kimoto, Eiji
    Kakiya, Ryusuke
    Tahara, Hideki
    Koyama, Hidenori
    Emoto, Masanori
    Tabata, Tsutomu
    Nishizawa, Yoshiki
    ATHEROSCLEROSIS, 2009, 207 (02) : 579 - 584
  • [3] Atypical angiopoietin-like protein that regulates ANGPTL3
    Quagliarini, Fabiana
    Wang, Yan
    Kozlitina, Julia
    Grishin, Nick V.
    Hyde, Rhonda
    Boerwinkle, Eric
    Valenzuela, David M.
    Murphy, Andrew J.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (48) : 19751 - 19756
  • [4] Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia
    Wiggins, Barbara S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (05) : e631 - e640
  • [5] Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (31) : 5159 - 5174
  • [6] Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)
    Ginsberg, Henry N.
    Goldberg, Ira J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (03) : 388 - 398
  • [7] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Tarugi, Patrizia
    Bertolini, Stefano
    Calandra, Sebastiano
    JOURNAL OF BIOMEDICAL RESEARCH, 2019, 33 (02): : 73 - 81
  • [8] Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
    Patrizia Tarugi
    Stefano Bertolini
    Sebastiano Calandra
    TheJournalofBiomedicalResearch, 2019, 33 (02) : 73 - 81
  • [9] Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
    Kosmas, Constantine E.
    Bousvarou, Maria
    Sourlas, Andreas
    Papakonstantinou, Evangelia J.
    Genao, Edilberto Pella
    Uceta, Rogers Echavarria
    Guzman, Eliscer
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2022, 14 : 49 - 59
  • [10] Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome
    Vatannejad, Akram
    Salimi, Fouzieh
    Moradi, Nariman
    Fouani, Fatima Zahraa
    Zandieh, Zahra
    Ansaripour, Soheila
    Sadeghi, Asie
    Fadaei, Reza
    LIFE SCIENCES, 2020, 263